Remove 2017 Remove Epilepsy Remove Patients
article thumbnail

The Top Medical Cannabis Research of 2017

MGC Pharma

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

article thumbnail

Which states allow out-of-state patients to buy medical marijuana?

Veriheal

However, the number of states that will authorize qualified patients from out-of-state medical marijuana programs is still relatively small. . Many places will either permit patients access to dispensaries and/or permit medical cannabis possession within a reasonable amount. Seizures, including those characteristic of epilepsy.

Patients 119
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Patient Stories: How MMJ is Changing Lives in West Virginia

MMJ Recs

The real stories around medical marijuana (MMJ) are those of the patients who have experienced life-changing benefits from cannabis therapy. The positive impact it’s having on the lives of patients across West Virginia is significant. MMJ can help patients achieve better sleep patterns and improved overall health.

article thumbnail

Nevada veterinarians can now treat patients with certain cannabis products

Cannabis Law Report

1, 2017, following a 2016 ballot measure. I certainly hope that other states follow Nevada’s lead and provide reassurances to licensed veterinarians that they can administer CBD or talk about it with patients without fear of facing disciplinary proceedings,” he said. But do medical cannabinoids actually help animal patients?

Patients 105
article thumbnail

GW suffers major blow as US sinks bid to patent cannabinoids for epilepsy

Cannabis Law Report

British firm GW Pharmaceuticals is licking its wounds after US judges tossed out its attempt to patent multiple cannabinoids for epilepsy treatment following an eight-year battle. The patent, which has been embroiled in dispute since 2010, is for “the use of one or more cannabinoids in the treatment of epilepsy”.

article thumbnail

The Latin American Cannabis Landscape – Part Two: Regulated Markets and Patient Access

CannaTech

Thanks to the recent emergence of regulated medical cannabis markets, the success of this versatile plant can be followed from farm to pharma and prescriber to patient, however, the origins of cannabis as medicine cannot be as simply traced as the plant is today from seed to sale. Of course, patients need product and product costs money.

Access 89
article thumbnail

Serious Conditions Are Responding To Cannabinoid Therapy

Peninsula Alternative Health

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. tetrahydrocannabinol (THC).